• to reduced the potential risk of major cardiovascular (heart and blood vessel) issues in Older people with form 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk printed a study on scientific journal Character a few novel glucose-sensitive insulin NNC2215 which will lessen the potential risk of hypoglycemia in animal products.[67]This insu